Endometrial Cancer Trial, Recruiting (NCT03624712)

Endometrial Cancer Trial, Recruiting NCT03624712 Sponsor: University Hospital Tuebingen Condition: Endometrial Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT03624712 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometrial Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with a confirmed uterine cancer, including cervical cancer, endometrial cancer, or sarcoma
If the cancer can be operated on, people who are planned to have surgery (either keyhole/robotic surgery or open surgery) as the main treatment
People who are willing and able to take part in all parts of the study
People aged 18 or older
People who have given written agreement to participate

Who may not be able to join:

People who have had a serious or sudden general illness in the last 4 weeks
People with an ongoing or long-term mental health or psychiatric condition
People for whom other concerns make study participation unsuitable — for example, high levels of acute personal or social stress, not being able to fully understand what the study involves, or not having sufficient German language skills (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03624712

Sponsor: University Hospital Tuebingen

Phase: Not Applicable

Status: Recruiting

Condition: Endometrial Cancer

More information: https://clinicaltrials.gov/study/NCT03624712

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with a confirmed uterine cancer, including cervical cancer, endometrial cancer, or sarcoma
If the cancer can be operated on, people who are planned to have surgery (either keyhole/robotic surgery or open surgery) as the main treatment
People who are willing and able to take part in all parts of the study
People aged 18 or older
People who have given written agreement to participate

Who may not be able to join:

People who have had a serious or sudden general illness in the last 4 weeks
People with an ongoing or long-term mental health or psychiatric condition
People for whom other concerns make study participation unsuitable — for example, high levels of acute personal or social stress, not being able to fully understand what the study involves, or not having sufficient German language skills (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital Tuebingen

Registry

ClinicalTrials.gov

Start date

1 January 2012

Est. completion

1 December 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

CTC and DTC analysis; HPV; DNA; Douglas cytology; Proteomic analysis; Sentinel lymph nodes; Peripheral nerve conduction velocity; Urodynamic- cystomanometry between pre an post radical gynecological surgeryuroflowmetry; CTC and DTC analysis; Urodynamic- urethral pressure profile between pre an post radical gynecological surgeryuroflowmetry; Urodynamic- uroflowmetry between pre an post radical gynecological surgeryuroflowmetry

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov